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SUMMARY
Opportunistic diseases in HIV-infected patients have changed since the introduction of highly active anti-retroviral therapy (HAART).
This study aims at evaluating the frequency of associated diseases in patients with AIDS admitted to an university hospital of Brazil,
before and after HAART. The medical records of 342 HIV-infected patients were reviewed and divided into two groups: group 1
comprised 247 patients before HAART and, group 2, 95 patients after HAART. The male-to-female rate dropped from 5:1 to 2:1 for
HIV infection. There was an increase in the prevalence of tuberculosis and toxoplasmosis, with a decrease in Kaposi’s sarcoma,
histoplasmosis and cryptococcosis. A reduction of in-hospital mortality (42.0% vs. 16.9%; p = 0.00002) has also occurred. An
agreement between the main clinical diagnoses and autopsy findings was observed in 10 out of 20 cases (50%). Two patients with
disseminated schistosomiasis and 2 with paracoccidioidomycosis are reported. Overall, except for cerebral toxoplasmosis, it has been
noticed a smaller proportion of opportunistic conditions related to severe immunosuppression in the post HAART group. There was
also a significant reduction in the in-hospital mortality, possibly reflecting improvement in the treatment of the HIV infection.
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INTRODUCTION
We now know that untreated human immunodeficiency virus (HIV)
disease often progresses in most infected persons from clinically silent
infection detectable only by laboratory tests to severe immunologic
dysfunction, resulting in the acquired immunodeficiency syndrome
(AIDS).
Untreated patients with manifestations of advanced HIV disease
frequently have CD4+ lymphocytes counts below 200 cells/mm3,
increased plasma HIV RNA levels, and clinical manifestations indicative
of severe immunocompromise, including conditions qualifying as CDC-
defined AIDS4. In this scenario, thence, opportunistic infection is
common.
Striking subjective and objective clinical improvement occurs in
patients with significant symptomatic HIV disease, including many with
AIDS and CD4+ counts below 100 cells/mm3, who begin an appropriate
HAART (highly active antiretroviral therapy) regimen, adhere
successfully to it, and do not experience significant adverse medication
effects.
The concept of AIDS as end-stage immunodeficiency is somewhat
clouded by the recent advances in antiretroviral therapy, which may
produce improvement in immunologic function, in AIDS-defining criteria
(such as CD4+ count below 200 cells/mm3), and in the incidence of
opportunistic infections15,17,22,23,28.
The relative frequencies of specific opportunistic diseases may vary
in different countries and even in different areas within the same country8,16.
We conducted this retrospective study to determine the spectrum of
opportunistic infections and malignancies in hospitalized patients, before
and after the introduction of the HAART regimen, in a General University
Hospital of Belo Horizonte, state of Minas Gerais, in Brazil.
MATERIAL AND METHODS
Patients: We reviewed the medical records of 342 HIV-infected
patients seen from February 1989 to December 2000 at the General
Hospital of the Federal University of Minas Gerais, in Brazil. Patients
were divided into two groups: group 1 (247 patients) admitted to hospital
from 1989 to 1996 and group 2 (95 patients) admitted after December
1996. The patients were referred to us because they presented symptoms
presumed to be due to HIV infection or were admitted to hospital to
investigate signs or symptoms of unknown origin, such as prolonged
fever14. A standardized questionnaire was filled out for each and every
patient containing epidemiological data, the presenting clinical profile
and all tests contributing to a diagnosis.
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Diagnosis of opportunistic diseases: The diagnosis of Pneumocystis
carinii pneumonia was accepted in patients who responded to treatment
with trimethoprim-sulfametoxazole, and had a convincing clinical picture
and radiological findings. One patient from each group had the agent
identified in the bronchoalveolar lavage. The diagnosis of tuberculosis
was based on the identification of the agent in tissues or sputum (Ziehl-
Nielsen staining, and culture were routinely performed when tuberculosis
was suspected); also, a complete response of symptoms to treatment
with rifampin, isoniazid and pyrazinamide and suggestive histological
findings in biopsy specimens were considered diagnostic. The diagnosis
of Mycobacterium avium complex (MAC) was admitted when acid fast
bacilli were recovered from tissues or blood, the symptoms were
consistent with MAC infection, the CD4+ T-lymphocytes count was
below 100, and a good clinical response was obtained with clarithromycin
associated with ethambutol.
Toxoplasmic encephalitis was diagnosed when a patient with a
convincing clinical picture had abnormal and suggestive computed
tomographic scan or magnetic resonance imaging of the brain. A
satisfactory response to antitoxoplasma therapies and positive serum IgG
antibody to Toxoplasma gondii were also required. Brain biopsies were
performed in cases which the standard treatment for toxoplasmosis failed.
Cryptococcal meningitis was diagnosed when there was evidence of
neurological involvement and a lumbar puncture revealed positive China
ink preparation for fungi. The other opportunistic diseases were diagnosed
according to criteria suggested by CDC4.
Autopsy: 17 individuals (3.9%) from group 1 and 3 (3.2%) from
group 2 were submitted to autopsy (non-probabilistic sample) following
the protocol of the Department of Pathology of the Faculty of Medicine,
Federal University of Minas Gerais, Brazil.
HIV serology: All samples were tested by an enzyme-linked
immunosorbent assay (Abbot Laboratories, California-USA). Positive
samples were retested by ELISA and subsequently by Western blot
(Sanofi Diagnostics, Pasteur Inc., France). A Western blot was judged to
be positive if both core and envelope bands (p24 and gp120/160 or gp41)
were present (CDC/ASTPHLD criteria).
The treatment of AIDS: The treatment of AIDS before 1996 was
mostly performed using single agents like zidovudine (ZDV). Highly
active antiretroviral therapy (HAART) was considered in the present
study a regimen containing a protease inhibitor and two older nucleoside
analogues, such as zidovudine (ZDV) and lamivudine (3TC).
Statistical analysis: The information obtained was stored in a
computer data bank using the Epi Info version 6 software. The chi-
squared and t (Student) tests were respectively used to analyze differences
in proportions and means.
RESULTS
Profile of the patients: There was no significant difference of age
distribution and CD4+ cell counts between the two groups (Table 1).
206 out of 247 (83.4%) group 1 patients and 64 out of 95 (67.4%) group
2 patients were male (male-to-female ratio of 5:1 and 2:1, respectively).
The proportion of sexual transmission was high in both groups (99 out
of 131; 75.6% in group 1 and 51 out of 61; 83.6% in group 2), but there
was a higher participation of heterosexual practice as risk factor in group
2 patients (22.1% vs. 54.1%) (Table 1). The time spent in hospital was
different between the two groups (mean of 19.2 and 32.7 days,
respectively for groups 1 and 2; p = 0.001). 104 patients (42%) in group
1 and 16 patients (16.9%) in group 2 died during hospitalization (p =
0.00002).
Opportunistic infections: The signs and symptoms which brought
patients to hospital in search for help and clinical investigation varied.
The main organs affected at admission were not different among the
groups: the respiratory system, central nervous system, digestive system
and blood elements.
The frequency of opportunistic infections among the 342 patients is
shown in Table 2. 460 diagnoses were described in group 1 patients
(mean: 1.9 per patient; range: 1 to 6) and 272 in group 2 (mean 2.9 per
patient; range: 1 to 6). The most common opportunistic conditions were
similar, but there was a drop of Kaposi’s sarcoma (23 vs. 3 patients; p =
0.08), meningeal cryptococcosis (16 vs. 5; p = 0.86) and histoplasmosis
(4 vs. 0 patients; p = 0.270) prevalence in group 2 when compared to
group 1. Also, an increase in the occurrence of tuberculosis (23 vs. 25
Table 1
Baseline characteristics of patients with AIDS admitted to a General
University Hospital in Brazil in the period of February 1989 to December
2000. Group 1 = patients admitted to hospital before HAART was available;
Group 2 = after HAART became available
Characteristics No. of Patients (%)
Group 1 Group 2
Age in years (mean±standard deviation)  37.4±11.2  35.0±10.8
15-19  7 (2.8) 3 (3.2)
20-39  150 (60.7) 65 (68.4)
40-59  79 (32.0) 23 (24.2)
> 60  11 (4.5) 4 (4.2)
Mode of transmission of HIV
Homosexual  54 (21.8) 15 (15.7)
Heterosexual  29 (11.7) 33 (34.7)
Bisexual  16 (6.4) 3 (3.1)
Transfusion of blood or  18 (13.7) 2 (2.1)
blood derivatives
IDUsa  13 (7.2) 7 (7.3)
Occupational exposure  1 (0.4) 1 (1.0)
Unknown  116 (46.9) 34 (35.7)
Total  247 (100) 95 (100)
CD4+ lymphocyte count/µL  131.1±164.3  124.4±152.0
(mean±standard deviation)
<100  57 (61.3) 42 (60.8)
100-199  17 (18.3) 14 (20.3)
200-299 9 (9.7) 6 (8.7)
300-399 3 (3.2) 3 (4.3)
400-499 2 (2.2) 1 (1.4)
> 500  5 (5.4) 3 (4.3)
Total  93 (100) 69 (100)
HAART = highly active anti-retroviral therapy; a injecting drug users; refusals
and not stated removed from table
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patients; p = 0.0001) and toxoplasmosis (11 vs. 13 patients; p = 0.005)
was noticed.
Overall, candidiasis was the main clinical diagnosis, followed in
different proportions for group 1 and 2 by tuberculosis, Pneumocystis
carinii pneumonia, herpes simplex virus infection, central nervous system
toxoplasmosis, sepsis and cryptococcosis.
Tuberculosis was one of the most common opportunistic infections
diagnosed. If we consider the last admission to hospital and the history
of previous treatment for tuberculosis, 91 patients (36.8%) in group 1
and 33 patients (34.7%) in group 2 had tuberculosis.
Paracoccidioidomycosis: Two group 1 patients were diagnosed
during hospitalization as having disseminated paracoccidioidomycosis.
Both presented pulmonary involvement. An illustrative case is
summarized here: he was a 48 year-old, heterosexual promiscuous man,
who was admitted to hospital with a history of diffuse abdominal pain,
diarrhea and skin lesions which appeared 15 days earlier. He was
receiving zidovudine monotherapy for AIDS for the last 12 months. He
was skinny, complained of paresthesia of the lower limbs and fatigue,
and was unable to walk without support. There was oral thrush. The
spleen was palpable 4 cm below the left costal margin. The skin lesions,
affecting the limbs, especially the legs, were in different stages of
evolution, with areas of erythema, ulcers and pustules. A biopsy of one
of them revealed the presence of Paracoccidioides brasiliensis. A chest
x-ray disclosed a diffuse reticule-nodular pattern. The CD4+ count was
of 17 cells/mm3. Amphotericin B (40 mg/day) in the total dose of 3.8g
was offered. There was a slow but steady improvement in the clinical
picture and the patient was discharged from hospital two months after
admission in good condition. A chest x-ray taken 3 months later showed
disappearance of the micro-nodules. The skin ulcers healed completely
leaving brownish scars.
Autopsy: Brain and lungs were the organs most frequently affected
during autopsy. The association of diseases was reported for all patients.
Tuberculosis, toxoplasma encephalitis, pulmonary pneumocystosis and
disseminated CMV disease were the main findings. Primary lymphoma
of the central nervous system was described in three individuals; in one,
lymphoma was found to be associated to three other diseases, namely:
toxoplasma encephalitis, cryptococcal meningitis and HIV
encephalopathy. Three individuals presented severe myocarditis and in
one, Toxoplasma gondii was identified as the causal agent.
Three other patients had Schistosoma mansoni infection, and in two
of them there was a miliary distribution of eggs in many organs (liver,
spleen, lungs, intestine, pancreas and testes). They were male of 33 and
53 years of age. Small and incomplete granulomas were observed around
the eggs deposited in the tissues. In the liver there was no evidence of
Symmers fibrosis; also, no signs of portal hypertension were found. In
both, miliary tuberculosis was the main AIDS-related opportunistic
disease. Intestinal perforation caused by tuberculosis was described in
one patient.
Other associated diseases were: candidiasis (5 cases), disseminated
histoplasmosis (1 case) and pseudomembranous colitis (1 case), severe
HIV leucoencephalopathy (1 case) and bacterial bronchopneumonia (1
case).
Table 2
Prevalence of the main opportunistic infections and malignancies in 342 HIV-infected patients seen at the General Hospital of the Federal University of
Minas Gerais, in Brazil, from February 1989 to December 2000. Group 1 = patients admitted to hospital before HAART was available;
Group 2 = after HAART became available
Condition No. (%) of patients
Group 1 Group 2 (p < 0.05)
Opportunistic infections
Candidiasisa 108 (43.7) 33 (34.7) NS
PCPb 31 (12.6) 15 (15.8) NS
Herpes simplex 30 (12.1) 12 (12.6) NS
Sepsis 25 (10.1) 7 (7.4) NS
Tuberculosis 23 (9.3) 25 (26.3) S
Cryptococcal meningitis 16 (6.5) 5 (5.2) NS
Toxoplasma encephalitis 11 (4.4) 13 (13.7) S
Cryptosporidium parvum in the stools 7 (2.8) 1 (1.1) NS
CMVc disseminated 5 (2.0) 1 (1.1) NS
Histoplasmosis 4 (1.6) 0 NS
Mycobacterium avium complex 3 (1.2) 1 (1.1) NS
Neoplasias
Kaposi’s sarcoma 23 (9.3) 3 (3.2) NS
Lymphoma (non-Hodgkin’s) 4 (1.6) 2 (2.1) NS
Primary lymphoma of the CNSd 3 (1.2) 1 (1.1) NS
aorofaringeal candidiasis occurred in 70% of the cases; bPneumocystis carinii pneumonia; ccytomegalovirus; dcentral nervous system; there is
usually more than one diagnose by patient; refusals and not stated removed from Table
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There was an agreement between the main clinical diagnoses and
the main findings in autopsy in 10 out of 20 cases (50%). Clinical
diagnoses, otherwise, missed a large number of associated diseases.
DISCUSSION
We retrospectively analyzed the spectrum of opportunistic diseases
diagnosed in a large series of AIDS patients in Brazil, before and after the
use of highly active antiretroviral therapy. In 20 individuals the diagnoses
were then compared with autopsy reports. The overall male-to-female ratio
dropped from 5:1 to 2:1 and homosexuality or bisexuality were substituted
for heterosexuality as the main risk behavior for HIV infection. These
observations follow the tendency observed in the AIDS epidemic in Brazil
obtained from the notification of cases to the National Institute of Health3.
Notwithstanding therapeutic improvements, patients still reach the hospital
with severe disruption of the immune system documented by a CD4+
lymphocyte count in both groups under 200 cells/mm3 in 80% of patients.
Patients of Group 1 spent a shorter time in hospital and that can be explained
by the higher mortality rate before 1996.
A decrease in the number of patients with Kaposi’s sarcoma and
histoplasmosis in the post HAART group (not reaching statistical
significance) has been observed. Yet, the number of cases of tuberculosis
and toxoplasmosis increased (respectively, 23 vs. 25 cases; p = 0.0001
and 11 vs. 13 cases; p = 0.005). In general, the prevalence of tuberculosis
was higher than that reported for the United States (9% - 18%)9.
Tuberculosis in these patients was highly pathogenic, with involvement
of at least one extra pulmonary organ in most cases.
An increase in the prevalence of tuberculosis and toxoplasmosis in
group 2 has been observed, and this is probably explained by the greater
awareness of physicians about both diseases and improvement in the
diagnostic methods (such as, CT scan, magnetic resonance imaging, brain
biopsy, PCR).
In the last years we have learnt that no group of people or region is
protected from the threat of AIDS2,25. But, determining the spectrum of
opportunistic infections in a given region requires surveillance systems
and diagnostic services that may not be available in many developing
countries. For example, opportunistic infections that can be diagnosed
with reasonable accuracy by physical examination (e.g., oral candidiasis)
or by inexpensive laboratory techniques (e.g., China ink stain of
cerebrospinal fluid for Cryptococcus neoformans) may be documented
more frequently than opportunistic infections requiring more expensive
diagnostic technologies (e.g., Pneumocystis carinii pneumonia,
disseminated Mycobacterium avium complex (MAC), cytomegalovirus
disease). Biases in diagnosing and reporting opportunistic infections may
be especially important among socially disadvantaged groups with limited
access to diagnostic and health care services8. Finally, differences in
clinical definitions may make comparisons between published reports
difficult. For these reasons, much less is known about the frequency of
different opportunistic infections in the developing world than in
industrialized countries6,16,19.
The first two patients with paracoccidioidomycosis and AIDS were
reported in 198924. The largest published review of cases of
paracoccidioidomycosis and AIDS involved 27 cases7 and except for
one patient from Venezuela, all the reported cases of this association
occurred in Brazil. Since then, another 15 patients have been reported,
being two from Colombia27. A wide spectrum of clinical manifestations
was seen in the 27 patients described in 19957, ranging from indolent
infection to rapidly progressive disease. More than one extra pulmonary
organ was involved in 19 patients (70.4%), with disseminated disease
being the most common form of paracoccidioidomycosis. We add here
two more cases of paracoccidioidomycosis to the medical literature. Both
patients had pulmonary involvement with a micronodular pattern, very
much like the miliary pattern seen in disseminated tuberculosis. One
had associated skin lesions, and this patient presented a good clinical
and radiological response to treatment with amphotericin B. The other
patient died in coma of a disease diagnosed clinically as toxoplasma
encephalitis; as permission for autopsy was not granted involvement of
the brain by Paracoccidioides brasiliensis can not be excluded. The small
number of cases of paracoccidioidomycosis in patients with AIDS in
Latin America has been attributed to the widespread use of trimethoprim-
sulfamethoxazole as prophylaxis for Pneumocystis carinii pneumonia.
With the spread of AIDS to rural areas of Brazil an increase in the number
of cases of associated paracoccidioidomycosis is to be expected.
Three out of 20 patients had severe myocarditis diagnosed during
autopsy; in one individual Toxoplasma gondii was identified as the
causative agent. Of note, no signs or symptoms of cardiac disease were
observed and documented in the medical records of the 3 cases.
Myocarditis in HIV patients may play a role in the development of
ventricular dysfunction. The incidence of myocarditis at autopsy has
been described in one third of all AIDS patients. A specific cause was
found in less than 20% of these patients26. Common pathogens in AIDS
myocarditis include Toxoplasma gondii, M. tuberculosis, and
Cryptococcus neoformans. Other infectious organisms have been reported
to include Mycobacterium avium-intracellulare complex, Aspergillus
fumigatus, Candida albicans, Histoplasma capsulatum, Coccidioides
immitis, cytomegalovirus, herpes simplex and T. cruzi. Recent data
suggest that HIV alone can cause myocarditis. Either HIV or its proteins
have been found in the heart specimens of patients with AIDS with and
without cardiac diseases by culture, by in situ deoxyribonucleic acid
hybridization, and by Southern blot tests1,21.
Three patients had schistosomiasis mansoni described only after death
and two of them presented a miliary distribution of eggs in many organs.
Stool examination did not reveal eggs of the worm in one patient. In
both, incomplete granulomas were described and they also were found
to have concomitant miliary tuberculosis (one, with intestinal perforation
attributed to tuberculosis). Data on the behavior of schistosomiasis in
the immunosuppressed host are rather scarce. The migration of S. mansoni
worms to different organs in the human body may explain the finding of
a great number of eggs in unusual places. This hypothesis implies that
the immune system is important in keeping the adult worms confined to
the mesenteric vessels. A chronic miliary form of schistosomiasis in
patients with portal hypertension has previously been described but our
patients did not have the hepatosplenic form of the disease12. It is also
interesting to note that egg output decreases sharply in mice
experimentally infected with S. mansoni and immunosuppressed by drugs
or thymectomy; a well-formed granuloma facilitates the migration of
eggs in host tissues5. Without granuloma formation S. mansoni eggs do
not reach the gut lumen and diagnosis of schistosomiasis based on the
stool examination is not possible; rectal or liver biopsies and ELISA for
circulating antigens would be an alternative to stool examination in this
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context9,11,20. It is worth mentioning that in the autopsy of a patient (HIV
negative) with Salmonella-S. mansoni association, reported in 199312,
miliary tuberculosis was also described, as well as S. mansoni eggs
disseminated in the liver, pancreas, spleen and testes and with incomplete
granulomas around the eggs. In the two patients presented here the CD4+
counts in the blood were not too low (126 and 256, respectively) showing
that the immunodeficiency was not so severe. Therefore, the association
with miliary tuberculosis in our cases may not be a coincidence and a
role for this disease (causing more consumption and/or aggravating the
disruption of the immune system) in the dissemination of schistosomiasis
should be considered.
A comparison between clinical and autopsy data indicates that a
significant number of associated diseases remains without a diagnosis
during HIV infection. Major clinical efforts should be directed to
identifying CMV infection, mycotic diseases (paracoccidioidomycosis
should be added to other mycosis affecting AIDS patients in Latin
America), schistosomiasis, extrapulmonary tuberculosis and central
nervous system diseases, such as, cerebral lymphoma. It is also desirable
to know more about the impact of the diseases of developing countries
on HIV infection and its evolution 9,20.
RESUMO
Infecções oportunistas em pacientes com aids internados em um
hospital universitário do sudeste do Brasil
O espectro das doenças oportunistas em pacientes com aids vem se
modificando desde a introdução da terapia antiretroviral altamente eficaz
(HAART). O objetivo deste estudo é o de avaliar o perfil das afecções
oportunistas em pacientes com aids internados em um hospital
universitário do Brasil, comparando os períodos pré e pós-utilização da
terapia HAART. Para tanto, revisaram-se os prontuários médicos de 342
pacientes infectados pelo HIV, dividindo-os em dois grupos: grupo 1,
composto de 247 pacientes pré-HAART e grupo 2, composto de 95
pacientes pós-HAART. A relação homem-mulher caiu de 5:1 para 2:1.
Houve aumento da prevalência da tuberculose e da toxoplasmose, com
redução da prevalência do sarcoma de Kaposi, da histoplasmose e da
criptococose. Observou-se ainda significativa redução da mortalidade
intra-hospitalar (42% vs. 16,9%; p = 0,00002). A concordância entre o
principal diagnóstico clínico e anatomopatológico foi observada em 10
de 20 pacientes necropsiados (50%). São relatados dois pacientes com
esquistossomose disseminada e dois com paracoccidioidomicose. Em
conclusão, excetuando-se a toxoplasmose, houve redução das doenças
oportunistas relacionadas à imunossupressão grave nos pacientes pós-
HAART. Observou-se significativa redução da mortalidade intra-
hospitalar, possivelmente refletindo a melhora do tratamento dos
pacientes HIV-positivos em nosso meio.
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